US signs $326 million contract to develop therapy to block infections

WASHINGTON D.C.: The US government announced the signing of a $326 million contract with Regeneron Pharmaceuticals for a next-generation Covid-19 antibody therapy for preventing infections.

In 2020, Regeneron developed an antibody therapy against COVID-19, which was authorized by the US Food and Drug Administration (FDA) in November that year but saw limited use after it was found to be less effective against th